Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection
Lin, Y.; Sobis, H.; Vandeputte, M.; Waer, M.
Transplantation Proceedings 27(1): 286-287
1995
ISSN/ISBN: 0041-1345 PMID: 7879005 Document Number: 451655
Document emailed within 1 workday
Related Documents
Sudo, T.; Aruga, A.; Shimizu, K.; Matsushita, N.; Takasaki, K. 2006: OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer Anticancer Research 26(6b): 4327-4333Pinto, M.E.; Nelson, R.A. 1975: The effect of antibody and complement on perfused hearts: a model for the study of xenograft rejection phenomenon Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 149(1): 78-93
Ng, A.K.; Indiveri, F.; Pellegrino, M.A.; Molinaro, G.A.; Quaranta, V.; Ferrone, S. 1980: Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies Journal of Immunology 124(5): 2336-2340
Olinescu, A.; Hristescu, S. 1984: The human effector cells of natural cell mediated cytotoxicity (NCMC) and antibody dependent cellular cytotoxicity (ADCC) express a differentiate susceptibility to pronase Archives Roumaines de Pathologie Experimentales et de Microbiologie 43(2): 147-157
Metes, D.; Morel, P.A.; Nellis, J.; Fung, J.J.; Rao, A.S. 2001: Fcgamma Rllc 13Q/STP polymorphism influences the antibody-dependent cytotoxicity levels triggered by natural killer cells against pig aortic endothelial cells Transplantation Proceedings 33(1-2): 333
Simeonovic, C.J.; Wilson, J.D. 1992: Role of CD4+ and CD8+ T cells in proislet allograft and xenograft rejection Transplantation Proceedings 24(1): 252-253
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Kay, H.D.; Bonnard, G.D.; West, W.H.; Herberman, R.B. 1977: A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity Journal of Immunology 118(6): 2058-2066
Parrillo, J.E.; Fauci, A.S. 1978: Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody-dependent cellular cytotoxicity: differential sensitivity of effector cells to in vivo and in vitro corticosteroids Scandinavian Journal of Immunology 8(2): 99-107
Ahn, M.; Chang, E.; Chu, G.; Barker, C.F.; Markmann, J.F. 1995: Cellular requirements for pancreatic islet xenograft rejection Transplantation Proceedings 27(6): 3302-3303
Djeu, J.Y. 1982: Antibody-dependent cell-mediated cytotoxicity and natural killer-cell phenomenon Journal of the American Veterinary Medical Association 181(10): 1043-1048
Geller, R.L.; Bach, F.H.; Vercellotti, G.M.; Nistler, R.S.; Bolman, R.M.; Fischel, R.J.; Leventhal, J.; Platt, J.L. 1992: Activation of endothelial cells in hyperacute xenograft rejection Transplantation Proceedings 24(2): 592
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Cary, N.; Moody, J.; Yannoutsos, N.; Wallwork, J.; White, D. 1993: Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection Transplantation Proceedings 25(1 Pt 1): 400-401
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Fujita, S.; Hayasaka, Y.; Murakami, T.; Shinkai, M.; Kawai, T.; Fuchinoue, S.; Teraoka, S.; Agishi, T.; Ota, K. 1996: Prevention of hyperacute xenograft rejection by polyclonal antibodies against donor blood cells Transplantation Proceedings 28(2): 726-727
Gutiérrez, F.; Garrido, F.; Osorio, C. 1979: Antibody-dependent cellular cytotoxicity in humans. Relationship between lymphoid cells with Fc receptors and ADCC Sangre 24(2): 135-142
Woodhouse, C.S.; Morgan, A.C. 1989: Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis Cancer Research 49(10): 2766-2772
Takaki, K.; Harada, M.; Sairenji, T.; Hinuma, Y. 1980: Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome Journal of Immunology 125(5): 2112-2117
Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C. 2010: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 795-798